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Table S1. Baseline characteristics a and metabolic health status in members of the subcohort, by country 
 
 Denmark Greece Germany Italy Netherlands Spain Sweden United Kingdom 
N 1895 1124 1356 1800 1270 550 1481 998 
Age (years) 56.6 (4.4) 52.2 (12.2) 50 (8.7) 50.3 (7.9) 52.7 (10.7) 50.6 (8.4) 57.6 (7.7) 57 (10.7) 
Women (%) 46.7 61.7 60.5 66.3 83.9 68.0 61.7 60.6 
MetS (%) 27.3 28.1 29.3 22.1 24.1 26.6 25.7 22.1 
Normal weight (%) 43.8 27.9 45.6 45.7 51.8 23.3 51.7 51.5 
Overweight (%) 42.6 42.0 39.3 39.4 36.4 46.9 37.0 37.5 
Obese (%) 13.7 30.1 15.1 14.8 11.8 29.8 11.3 11.0 
MHO (% of the obese) 38.6 55.0 31.7 46.8 48.7 57.9 37.1 40.9 
 
a Values are unadjusted means (SD) or percentages.  
 n= 10,474 members of the subcohort included in the analytical sample 
Abbreviations: MHO, metabolically healthy obese; MetS, metabolic syndrome
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Table S2. Sensitivity analysis: HR for CHD in different complete-case samples specific to each analysis. 
  
 HR 
a 95% CI p N cases N total I2 b 95% CI 
BMI and Waist Circumference 
Model 1 c  
    
   
BMI  1.24 (1.17, 1.30) <.0001 9212 23634 55% (6%, 79%) 
Waist circumference 1.31 (1.24, 1.38) <.0001 9212 23634 47% (0%, 76%) 
Model 2 d  
   
  
  
BMI  1.05 (0.97, 1.14) 0.23 9212 23634 33% (0%, 69%) 
Waist circumference 1.24 (1.12, 1.37) <.0001 9212 23634 40% (0%, 73%) 
Model 3 e  
   
  
  
BMI  1.06 (1.01, 1.10) 0.01 8319 18700 6% (0%, 68%) 
Waist circumference 1.07 (1.01, 1.14) 0.01 8319 18700 21% (0%, 63%) 
         
Metabolically-defined body size phenotypes 
Model B f         
BMI MetS        
Normal weight Metabolically Healthy 1.00 (ref) 
 
2833 7664   
Overweight Metabolically Healthy 1.26 (1.15, 1.38) <.0001 2513 6748 0% (0%, 68%) 
Obese Metabolically Healthy 1.41 (1.15, 1.72) <.0001 687 2159 47% (0%, 77%) 
Normal weight Metabolically Unhealthy 1.98 (1.67, 2.35) <.0001 530 929 0% (0%, 68%) 
Overweight Metabolically Unhealthy 2.26 (1.90, 2.67) <.0001 2172 3703 63% (19%, 83%) 
Obese Metabolically Unhealthy 2.44 (2.11, 2.82) <.0001 1356 2495 4% (0%, 69%) 
 
a Country-specific HRs were estimated from Prentice-weighted Cox proportional hazards models, and 95%CI estimated with robust variance, to take into 
account the case-cohort design. HRs were combined by multivariate random-effect meta-analysis across 8 countries. Age was used as the underlying time 
scale, models were stratified by sex and centre.  
b Heterogeneity across 8 European countries. 
c Model 1. HRs adjusted for age, smoking, physical activity, Mediterranean diet score, energy and alcohol intake, educational level 
d Model 2. Model 1 + waist circumference (for BMI) or BMI (for waist circumference) 
e Model 3. HRs adjusted for age, smoking, systolic blood pressure, total cholesterol, HDL cholesterol, history of diabetes 
f Model B. HRs adjusted for age, smoking, educational level, physical activity, Mediterranean diet score, energy and alcohol intake 
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Table S3. Sensitivity analysis: HR for CHD where missing values are imputed by multiple imputation 
   
HR a 95% CI p 
BMI and Waist Circumference 
Model 1 b 
    
BMI 
 
1.28 (1.24, 1.33) <.0001 
Waist circumference 1.32 (1.27, 1.39) <.0001 
Model 2 c 
    
BMI 
 
1.16 (1.07, 1.24) <.0001 
Waist circumference 1.15 (1.05, 1.25) 0.002 
Model 3 d 
    
BMI 
 
1.11 (1.06, 1.16) <.0001 
Waist circumference 1.10 (1.04, 1.16) <.0001 
Metabolically-defined body size phenotypes 
Model B e 
    
BMI MetS    
Normal weight Metabolically Healthy 1.00 (ref) 
 
Overweight Metabolically Healthy 1.35 (1.20, 1.52) <.0001 
Obese Metabolically Healthy 1.67 (1.39, 1.99) <.0001 
Normal weight Metabolically Unhealthy 1.78 (1.46, 2.18) <.0001 
Overweight Metabolically Unhealthy 2.22 (1.98, 2.49) <.0001 
Obese Metabolically Unhealthy 2.43 (2.09, 2.81) <.0001 
 
a HRs were estimated from Prentice-weighted Cox proportional hazards models, and 95%CI estimated with robust variance, to take into account the case-
cohort design. Age was used as the underlying time scale, models were stratified by sex and centre. N=25,653 (12,240 cases). 5 imputed datasets, results 
combined by Rubin’s rules. 
b Model 1. HRs adjusted for age, smoking, physical activity, Mediterranean diet score, energy and alcohol intake, educational level 
c Model 2. Model 1 + waist circumference (for BMI) or BMI (for waist circumference) 
d Model 3. HRs adjusted for age, smoking, systolic blood pressure, total cholesterol, HDL cholesterol, history of diabetes 
e Model B. HRs adjusted for age, smoking, physical activity, Mediterranean diet score, energy and alcohol intake, educational level
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Table S4. Sensitivity analysis: HR for CHD after exclusion of first two years of follow-up across metabolically-defined body size phenotypes 
 
BMI MetS HR a 95%CI p-value N cases N total I2 b 95% CI 
Model A c         
Normal weight Metabolically Healthy 1.00 (ref)  1802 5961   
Overweight  Metabolically Healthy 1.22 (1.10, 1.35) <.0001 1581 4241 0% (0%, 68%) 
Obese  Metabolically Healthy 1.24 (0.99, 1.57) 0.07 323 1059 37% (0%, 72%) 
Normal weight Metabolically Unhealthy 2.12 (1.74, 2.58) <.0001 428 778 0% (0%, 68%) 
Overweight  Metabolically Unhealthy 2.30 (1.96, 2.72) <.0001 1678 2946 50% (0%, 78%) 
Obese  Metabolically Unhealthy 2.54 (2.23, 2.91) <.0001 976 1829 0% (0%, 68%) 
Model B d           
Normal weight Metabolically Healthy 1.00 (ref)  1802 5961   
Overweight  Metabolically Healthy 1.23 (1.11, 1.37) <.0001 1581 4241 0% (0%, 68%) 
Obese  Metabolically Healthy 1.25 (0.99, 1.58) 0.06 323 1059 35% (0%, 71%) 
Normal weight Metabolically Unhealthy 2.09 (1.72, 2.54) <.0001 428 778 0% (0%, 68%) 
Overweight  Metabolically Unhealthy 2.29 (1.90, 2.75) <.0001 1678 2946 58% (7%, 81%) 
Obese  Metabolically Unhealthy 2.46 (2.14, 2.82) <.0001 976 1829 0% (0%, 68%) 
 
 
a Country-specific HRs were estimated from  Prentice-weighted Cox proportional hazards models, and 95%CI estimated with robust variance, to take into 
account the case-cohort design. HRs were combined by multivariate random-effects meta-analysis across 8 countries. Age was used as the underlying 
time scale, models were stratified by sex and centre.  n=16,814 (6,788 CHD cases). 
b Heterogeneity across 8 European countries 
c Model A. HRs adjusted for age, smoking, educational level. 
d Model B included the same variables as model A + physical activity, Mediterranean diet score, energy and alcohol intake 
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Table S5. Sensitivity analysis: HR for hard CHD (myocardial infarction) across metabolically-defined body size phenotypes 
 
BMI MetS HR a 95%CI p-value N cases N total I2 b 95% CI 
Model Ac 
        
Normal weight Metabolically Healthy 1.00 (ref)  1303 6165   
Overweight  Metabolically Healthy 1.23 (1.07, 1.41) 0.003 1144 4451 0% (0%, 68%) 
Obese  Metabolically Healthy 1.32 (1.01, 1.73) 0.045 234 1103 43% (0%, 75%) 
Normal weight Metabolically Unhealthy 2.13 (1.70, 2.67) <.0001 325 842 12% (0%, 71%) 
Overweight  Metabolically Unhealthy 2.21 (1.92, 2.55) <.0001 1283 3200 19% (0%, 62%) 
Obese  Metabolically Unhealthy 2.57 (2.17, 3.04) <.0001 773 1972 12% (0%, 72%) 
Model B d 
        
Normal weight  Metabolically Healthy 1.00 (ref)  1303 6165 
  
Overweight  Metabolically Healthy 1.24 (1.08, 1.43) 0.002 1144 4451 3% (0%, 69%) 
Obese  Metabolically Healthy 1.30 (1.00, 1.70) 0.049 234 1103 39% (0%, 73%) 
Normal weight Metabolically Unhealthy 2.10 (1.71, 2.58) <.0001 325 842 0% (0%, 68%) 
Overweight  Metabolically Unhealthy 2.21 (1.89, 2.57) <.0001 1283 3200 26% (0%, 67%) 
Obese  Metabolically Unhealthy 2.46 (2.10, 2.90) <.0001 773 1972 1% (0%, 68%) 
 
a Country-specific HRs were estimated from  Prentice-weighted Cox proportional hazards models, and 95%CI estimated with robust variance, to take into 
account the case-cohort design. HRs were combined by multivariate random-effects meta-analysis across 8 countries. Age was used as the underlying time 
scale, models were stratified by sex and centre. n=17,733 participants (5,062 CHD cases) 
b Heterogeneity across 8 European countries 
c Model A. HRs adjusted for age, smoking, educational level. 
d Model B included the same variables as model A + physical activity, Mediterranean diet score, energy and alcohol intake 
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Table S6. Sensitivity analysis: HR for CHD events across metabolically-defined body size phenotypes in non-smokers only 
 
BMI MetS HR a 95%CI p-value N cases N total I2 b 95% CI 
Model A c 
       




Overweight Metabolically Healthy 1.22 (1.04, 1.38) 0.003 1173 3215 0% (0%,68%) 
Obese Metabolically Healthy 1.26 (0.96, 1.67) 0.10 272 871 45% (0%,76%) 
Normal weight Metabolically Unhealthy 2.15 (1.72, 2.69) <.0001 277 506 0% (0%,68%) 
Overweight Metabolically Unhealthy 2.32 (2.00, 2.70) <.0001 1233 2193 7% (0%,70%) 
Obese Metabolically Unhealthy 2.59 (2.21, 3.03) <.0001 763 1443 0% (0%,68%) 
Model Bd 
       




Overweight Metabolically Healthy 1.23 (1.08,1.40) 0.002 1173 3215 47% (0%, 80%) 
Obese Metabolically Healthy 1.29 (0.99,1.67) 0.06 272 871 0% (0%, 79%) 
Normal weight Metabolically Unhealthy 2.15 (1.71,2.71) <.0001 277 506 35% (0%, 75%) 
Overweight Metabolically Unhealthy 2.32 (1.97,2.73) <.0001 1233 2193 44% (0%, 80%) 
Obese Metabolically Unhealthy 2.58 (2.18,3.04) <.0001 763 1443 0% (0%, 79%) 
 
a Country-specific HRs were estimated from  Prentice-weighted Cox proportional hazards models, and 95%CI estimated with robust variance, to take into 
account the case-cohort design. HRs were combined by multivariate random-effects meta-analysis across 8 countries. Age was used as the underlying time 
scale, models were stratified by sex and centre.  n=12,394 (4,911 cases) 
b Heterogeneity across 8 European countries 
c Model A. HRs age, smoking (never, former), educational level. 
d Model B included the same variables as model A + physical activity, Mediterranean diet score, energy and alcohol intake 
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Table S7. Sensitivity analysis: HR for CHD events with the highest level of certainty across metabolically-defined body size phenotypes 
 
BMI MetS HR a 95%CI p-value N cases N total I2 b 95% CI 
Model A c 
        




Overweight Metabolically Healthy 1.39 (1.04, 1.86) 0.03 325 2598 40% (0%, 78%) 
Obese Metabolically Healthy 1.11 (0.79, 1.55) 0.55 65 738 0% (0%, 79%) 
Normal weight Metabolically Unhealthy 2.58 (1.68, 3.95) <.0001 75 374 21% (0%, 66%) 
Overweight Metabolically Unhealthy 2.78 (2.17, 3.57) <.0001 389 1707 3% (0%, 80%) 
Obese Metabolically Unhealthy 2.99 (2.36, 3.79) <.0001 262 1218 0% (0%, 79%) 
Model Bd 
        




Overweight Metabolically Healthy 1.44 (1.05, 1.99) 0.03 325 2598 47% (0%, 80%) 
Obese Metabolically Healthy 1.13 (0.81, 1.59) 0.47 65 738 0% (0%, 79%) 
Normal weight Metabolically Unhealthy 2.79 (1.73, 4.49) <.0001 75 374 35% (0%, 75%) 
Overweight Metabolically Unhealthy 2.88 (2.09, 3.98) <.0001 389 1707 44% (0%, 80%) 
Obese Metabolically Unhealthy 2.93 (2.29, 3.77) <.0001 262 1218 0% (0%, 79%) 
 
a Country-specific HRs were estimated from  Prentice-weighted Cox proportional hazards models, and 95%CI estimated with robust variance, to take into 
account the case-cohort design. HRs were combined by multivariate random-effects meta-analysis across 8 countries. Age was used as the underlying time 
scale, models were stratified by sex and centre.  n=9,794 (1,384 cases) 
b Heterogeneity across 8 European countries 
c Model A. HRs adjusted for age, smoking, educational level. 
d Model B included the same variables as model A + physical activity, Mediterranean diet score, energy and alcohol intake 
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Table S8. Sensitivity analysis: HR for CHD across metabolically-defined body size phenotypes separately for men and women 
 
BMI MetS HR a 95%CI p-value N cases N total I2 b 95% CI 
Men 
       




Overweight Metabolically Healthy 1.32 (1.16, 1.51) <.0001 1168 2328 0% (0%,68%) 
Obese Metabolically Healthy 1.28 (0.99, 1.65) 0.06 184 415 7% (0%,70%) 
Normal weight Metabolically Unhealthy 2.53 (1.90, 3.37) <.0001 243 346 45% (0%,76%) 
Overweight Metabolically Unhealthy 2.35 (2.03, 2.73) <.0001 1239 1861 25% (0%,66%) 
Obese Metabolically Unhealthy 2.47 (2.06, 2.95) <.0001 622 954 0% (0%,68%) 
Women 
       
Normal weight Metabolically Healthy 1.00 (ref)  925 3855   
Overweight Metabolically Healthy 1.19 (1.03, 1.38) 0.02 609 2123 0% (0%,68%) 
Obese Metabolically Healthy 1.28 (1.02, 1.60) 0.03 176 688 0% (0%,68%) 
Normal weight Metabolically Unhealthy 1.85 (1.48, 2.31) <.0001 248 496 0% (0%,68%) 
Overweight Metabolically Unhealthy 2.36 (2.01, 2.76) <.0001 677 1339 26% (0%,67%) 
Obese Metabolically Unhealthy 2.72 (2.27, 3.26) <.0001 493 1018 30% (0%,69%) 
 
a Country-specific HRs were estimated from  Prentice-weighted Cox proportional hazards models, and 95%CI estimated with robust variance, to take into 
account the case-cohort design. HRs were combined by multivariate random-effects meta-analysis across 8 countries. Age was used as the underlying time 
scale, models were stratified by sex and centre.  n=8,214 men (4,509 cases) and n=9,519 (n=3,128 cases). 
HRs adjusted for age, smoking (never, former), educational level, physical activity, Mediterranean diet score, energy and alcohol intake 
b Heterogeneity across 8 European countries 
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Table S9. Sensitivity analysis: HR for CHD in metabolically-defined body size phenotypes where the definition of MetS does not include the waist 
circumference criterion 
 
BMI MetS without WC HR a 95%CI p-value N cases N total I2 b 95% CI 
Model A c       
  
Normal weight Metabolically Healthy 1.00 (ref)  1458 5166   
Overweight Metabolically Healthy 1.36 (1.20, 1.56) <.0001 1532 3999 6% (0%, 69%) 
Obese Metabolically Healthy 1.43 (1.13, 1.81) 0.003 357 1095 42% (0%, 74%) 
Normal weight Metabolically Unhealthy 2.01 (1.72, 2.35) <.0001 1011 1841 19% (0%, 62%) 
Overweight Metabolically Unhealthy 2.52 (2.17, 2.94) <.0001 2161 3652 41% (0%, 74%) 
Obese Metabolically Unhealthy 2.92 (2.54, 3.34) <.0001 1118 1980 0% (0%, 68%) 
Model B d         
Normal weight Metabolically Healthy 1.00 (ref)  1458 5166   
Overweight Metabolically Healthy 1.38 (1.20, 1.57) <.0001 1532 3999 7% (0%, 70%) 
Obese Metabolically Healthy 1.43 (1.14, 1.81) 0.002 357 1095 39% (0%, 73%) 
Normal weight Metabolically Unhealthy 2.00 (1.72, 2.32) <.0001 1011 1841 8% (0%, 70%) 
Overweight Metabolically Unhealthy 2.49 (2.11, 2.94) <.0001 2161 3652 48% (0%, 77%) 
Obese Metabolically Unhealthy 2.82 (2.45, 3.25) <.0001 1118 1980 0% (0%, 68%) 
 
a Country-specific HRs were estimated from Prentice-weighted Cox proportional hazards models, and 95%CI estimated with robust variance, to take into 
account the case-cohort design. HRs were combined by multivariate random-effect meta-analysis across 8 countries. Age was used as the underlying time 
scale, models were stratified by sex and centre. n=17,733 participants (7,637 CHD cases) 
b Heterogeneity across 8 European countries 
c Model A. HRs adjusted for age, smoking, educational level. 
d Model B included the same variables as model A + physical activity, Mediterranean diet score, energy and alcohol intake 
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Table S10. Sensitivity analysis: HR for CHD in metabolically-defined body size phenotypes where “metabolically healthy” is defined as having 
none of the 4 abnormalities 
 
 
BMI Healthy defined as having 0 
abnormality 
HR a 95%CI p-value N cases N total I2 b 95% CI 
Model A c         
Normal weight Metabolically Healthy 1.00 (ref)  390 2148   
Overweight Metabolically Healthy 1.24 (0.99, 1.56) 0.06 260 1040 0% (0%, 68%) 
Obese Metabolically Healthy 1.15 (0.72, 1.84) 0.55 36 198 0% (0%, 68%) 
Normal weight Metabolically Unhealthy 1.93 (1.62, 2.31) <.0001 2079 4859 0% (0%, 68%) 
Overweight Metabolically Unhealthy 2.67 (2.29, 3.12) <.0001 3433 6611 0% (0%, 68%) 
Obese Metabolically Unhealthy 3.19 (2.64, 3.85) <.0001 1439 2877 0% (0%, 68%) 
Model B d         
Normal weight Metabolically healthy 1.00 (ref)  390 2148   
Overweight Metabolically Healthy 1.24 (0.99, 1.56) 0.06 260 1040 0% (0%, 68%) 
Obese Metabolically Healthy 1.21 (0.76, 1.92) 0.43 36 198 0% (0%, 68%) 
Normal weight Metabolically Unhealthy 1.94 (1.62, 2.32) <.0001 2079 4859 0% (0%, 68%) 
Overweight Metabolically Unhealthy 2.68 (2.28, 3.14) <.0001 3433 6611 0% (0%, 68%) 
Obese Metabolically Unhealthy 3.12 (2.57, 3.80) <.0001 1439 2877 2% (0%, 68%) 
 
a Country-specific HRs were estimated from  Prentice-weighted Cox proportional hazards models, and 95%CI estimated with robust variance, to take into 
account the case-cohort design. HRs were combined by multivariate random-effects meta-analysis across 8 countries. Age was used as the underlying 
time scale, models were stratified by sex and centre. n=17,733 participants (7,637 CHD cases) 
b Heterogeneity across 8 European countries 
c Model A. HRs adjusted for age, smoking, educational level. 
d Model B included the same variables as model A + physical activity, Mediterranean diet score, energy and alcohol intake 
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Table S11. Sensitivity analysis: HR for CHD in metabolically-defined body size phenotypes where obesity is defined by WC, and MetS does not 
include criteria on WC 
 
WC MetS without WC HR a 95%CI p-value N cases N total I2 b 95% CI 
Model A c         
Normal WC d Metabolically Healthy 1.00 (ref)  1653 5707   
Overweight e Metabolically Healthy 1.40 (1.15, 1.69) 0.001 1031 2729 55% (0%, 80%) 
Obese f Metabolically Healthy 1.37 (1.11, 1.69) 0.003 663 1824 50% (0%, 78%) 
Normal WC d Metabolically Unhealthy 1.96 (1.70, 2.25) <.0001 1143 2075 0% (0%, 68%) 
Overweight e Metabolically Unhealthy 2.43 (2.09, 2.82) <.0001 1340 2292 20% (0%, 62%) 
Obese f Metabolically Unhealthy 2.92 (2.47, 3.45) <.0001 1807 3106 47% (0%, 76%) 
Model B g         
Normal WC d Metabolically Healthy 1.00 (ref)  1653 5707   
Overweight e Metabolically Healthy 1.41 (1.17, 1.70) <.0001 1031 2729 53% (0%, 79%) 
Obese f Metabolically Healthy 1.39 (1.12, 1.73) 0.003 663 1824 51% (0%, 78%) 
Normal WC d Metabolically Unhealthy 1.94 (1.68, 2.24) <.0001 1143 2075 0% (0%, 68%) 
Overweight e Metabolically Unhealthy 2.43 (2.09, 2.84) <.0001 1340 2292 24% (0%, 65%) 
Obese f Metabolically Unhealthy 2.84 (2.38, 3.39) <.0001 1807 3106 50% (0%, 77%) 
Model C h         
Normal WC d Metabolically Healthy 1.00 (ref)  1653 5707   
Overweight e Metabolically Healthy 1.33 (1.10, 1.60) <.0001 1031 2729 44% (0%, 75%) 
Obese f Metabolically Healthy 1.22 (0.99, 1.51) 0.06 663 1824 25% (0%, 66%) 
Normal WC d Metabolically Unhealthy 1.93 (1.66, 2.24) <.0001 1143 2075 0% (0%, 68%) 
Overweight e Metabolically Unhealthy 2.26 (1.92, 2.66) <.0001 1340 2292 21% (0%, 63%) 
Obese f Metabolically Unhealthy 2.44 (1.99, 2.99) <.0001 1807 3106 25% (0%, 66%) 
 
a Country-specific HRs were estimated from  Prentice-weighted Cox proportional hazards models, and 95%CI estimated with robust variance, to take into 
account the case-cohort design. HRs were combined by multivariate random-effect meta-analysis across 8 countries. Age was used as the underlying time 
scale, models were stratified by sex and EPIC study centre. n=17,733 participants (7,637 CHD cases); b Heterogeneity across 8 countries;  
c Model A. HRs adjusted for age, smoking, educational level.;  
d Normal WC: WC<94 for men, 80 for women; e Overweight: 94≤WC<102 for men, 80≤WC<88 for women; f Obese: WC≥102 for men, 88 for women 
g Model B included the same variables as model A + physical activity, Mediterranean diet score, energy and alcohol intake 
h Model C included the same variables as model B + BMI 
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MHANW MUANW MHAOW MUAOW MHAO MUAO Total 
MHNW 4447 999 648 0 71 0 6165 
MUNW 0 394 0 391 0 57 842 
MHOW 1246 452 1905 0 848 0 4451 
MUOW 0 218 0 1753 0 1229 3200 
MHO 14 8 176 0 905 0 1103 
MUO 0 4 0 148 0 1820 1972 
Total 5707 2075 2729 2292 1824 3106 17733 
 
Abbreviations: MHNW, metabolically healthy normal weight; MUNW, metabolically unhealthy normal weight; MHOW, metabolically healthy 
overweight; MUOW, metabolically unhealthy overweight; MHO, metabolically healthy obese; MUO, metabolically unhealthy obese; MHANW, 
metabolically healthy abdominally normal weight; MUANW, metabolically unhealthy abdominally normal weight; MHAOW, metabolically healthy 
abdominally overweight; MUAOW, metabolically unhealthy abdominally overweight; MHAO, metabolically healthy abdominally obese; MUAO, 
metabolically unhealthy abdominally obese. 
 
Weighted kappa (95%CI), measuring agreement between two classifications, was 0.667 (0.660- 0.674) 
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Figure S1. Schematic representation of the EPIC-CVD case-cohort design and sample included 
in the complete-case analysis 
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Figure S2. Schematic representation of the analysis strategy 
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Figure S3. Country-specific HRs across metabolically-defined body size phenotypes compared 
to metabolically healthy normal weight, Model B a 
 
 
a Model B was adjusted for age, smoking, educational level, physical activity, Mediterranean diet 
score, energy and alcohol intake 
